IceCure’s ProSense Installation in India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country

Latest system installation in IceCure’s global commercial rollout of ProSense CAESAREA, Israel, May 31, 2023 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as…

About the Author

has written 38936 stories on this site.

Copyright © 2010 Business and Corporate News.